CNTA•benzinga•
Chardan Capital Initiates Coverage On Centessa Pharmaceuticals with Buy Rating, Announces Price Target of $30
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 8, 2025 by benzinga